Publications by authors named "Ximena Cid-Serra"
Cell-free DNA as a potential biomarker for acute myocardial infarction: A systematic review and meta-analysis.
Int J Cardiol Heart Vasc
August 2023
Background: Tissue necrosis releases cell-free deoxyribonucleic acid (cfDNA), leading to rapid increases in plasma concentration with clearance independent of kidney function.
Aim: To explore the diagnostic role of cfDNA in acute myocardial infarction (AMI).
Methods: This systematic review and -analysis included studies of cfDNA in patients with AMI and a comparator group without AMI.
Importance: There are accumulating data about the utility of diagnostic multiorgan focused clinical ultrasonography (FCU) in the assessment of patients admitted with cardiopulmonary symptoms.
Objective: To determine whether adding multiorgan FCU to the initial clinical evaluation of patients admitted with cardiopulmonary symptoms reduces hospital length of stay, hospital readmissions, and in-hospital costs.
Design, Setting, And Participants: This is a prospective, parallel-group, superiority, randomized clinical trial with a 1:1 allocation ratio.
The aim in this systematic review was to determine the effect of point-of-care ultrasound (POCUS) on the clinical decision-making process and patient outcomes in adults admitted to the general medicine ward. A comprehensive search was performed in MEDLINE (Ovid), EMBASE (Ovid), PubMed, the Cochrane Library, ClinicalTrials.gov, Scopus, LILACS and Cinahl.
View Article and Find Full Text PDFArticle Synopsis
- Pulmonary complications are the primary symptoms of COVID-19, with two distinct phenotypes identified: L-type (low elastance) and H-type (high elastance).
- Each phenotype exhibits unique clinical presentations, pathophysiological mechanisms, pulmonary mechanics, and imaging results, requiring different treatment approaches.
- A proposed management algorithm uses respiratory rate, oxygenation index, and lung ultrasound to help early identify patients needing intubation and improve monitoring of those with respiratory failure due to COVID-19.